Back to search

Article

REV1 Inhibition Enhances Radioresistance and Autophagy

2021-09-13

Abstract excerpt

Cancer therapy resistance is a persistent clinical challenge. Recently, inhibition of the mutagenic translesion synthesis (TLS) protein REV1 was shown to enhance tumor cell response to chemotherapy by triggering senescence hallmarks. These observations suggest REV1’s important role in determining cancer cell response to chemotherapy. Whether REV1 inhibition would similarly sensitize cancer cells to radiation...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
41899eba-61fc-578d-863f-f544ed75277d
DOI
10.20944/preprints202109.0202.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
REV1 Inhibition Enhances Radioresistance and AutophagyDOI 10.20944/preprints202109.0202.v1
Select a neighboring publication to make it the new centre.